about
Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertilityIn vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class.Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axisThe gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data.Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.Conditional Deletion of Bmal1 in Ovarian Theca Cells Disrupts Ovulation in Female Mice.Cancer targeted therapeutics: From molecules to drug delivery vehicles.Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix.Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats.Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH.An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer.Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.Cetrorelix in the treatment of female infertility and endometriosis.Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?Hypothalamic gonadotropin-releasing hormone (GnRH) receptor neurons fire in synchrony with the female reproductive cycle.Morphological and enzymatic changes caused by a long-term treatment of female rats with a low dose of gonadoliberin agonist and antagonistInhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.Luteinizing hormone-releasing hormone antagonists.Thymic involution: where endocrinology meets immunology.Peptides and peptide conjugates: therapeutics on the upward path.Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.Development and Validation of a Reversed-phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms.Overview of elagolix for the treatment of endometriosis.The ovarian reserve is depleted during puberty in a hormonally driven process dependent on the pro-apoptotic protein BMFAssessment of inhibin B as a biomarker of testicular injury following administration of carbendazim, cetrorelix, or 1,2-dibromo-3-chloropropane in Wistar han rats.Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenism.Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.A practical and scalable system for heteroaryl amino acid synthesis.
P2860
Q24244397-4F3B5E21-704E-4C16-A4D7-377BB508062BQ24530841-22387FE8-8F86-4E72-80EC-ACEA44479F8BQ24658067-6B297561-38F9-485A-B2A5-B2DF177C2871Q30686259-496A0F8F-E685-4F89-855A-2E467D09181AQ33230782-F3864C2A-9185-42CC-A5DF-1BD0663ECAC5Q33569779-5673ECAD-1F78-462E-853D-218D58482209Q33887986-481DD8D8-822E-4911-AFE7-B8ABE56C3B74Q33894753-DCC7D856-DC03-418C-BFB6-135B6571AA2EQ33947108-7B5BE79B-5F1B-44C7-B044-3DE6D54468A9Q34106692-4E90648E-B32D-4452-8C34-745021FF6CA6Q34214898-6EAD69E7-4FCD-4A68-8401-BB5A31C684F8Q34381078-746CEF1B-C7F3-4D3E-854C-198FE3B2924AQ34571550-54E876D9-D58C-4E5B-83D7-48A27E2DC947Q36001614-AB266BC2-C075-43B9-AC94-1B5F7465A0BEQ36496992-AC98A6B9-DFCD-453F-B832-6DE36B439930Q36577239-9B9FA070-52BE-406A-ABD1-DAA6308D890FQ37029375-DABD2D7E-9DB6-484E-B78A-2294D51A9CEFQ37415783-8E61D3C9-6778-4A69-9EB7-B69707C46740Q37598922-55E1EE61-D5BD-41E5-B455-2E858032DC83Q37638747-926297CE-09DB-4C05-9262-F9131EB957ACQ37939600-59AB7311-957D-4702-A400-CC25F4D3DA12Q38037191-9448D08D-FEF0-4DE7-99A3-EF700D68432AQ38110433-A9E9E222-C452-4300-A46B-B0FFF3875818Q38627852-98F8AB8E-2FCF-461A-9774-64DE411E4941Q38791644-B1F9EF40-8D63-4945-B8DD-27CD74B81AA6Q41169741-50F77BA3-CB34-4BEA-A454-0036DD69E2CDQ43585963-66B5B4E2-1BA1-4A20-B685-1CA3EE1CFB45Q44479459-A624837C-B83A-4E24-94E7-DE16CCC469B0Q46581349-DBAAD841-5E74-419B-A2C6-8BF01B9C3F8BQ55092040-EA398090-0397-4ABF-8061-FAAD0E944EEE
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The LHRH antagonist cetrorelix: a review.
@ast
The LHRH antagonist cetrorelix: a review.
@en
The LHRH antagonist cetrorelix: a review.
@nl
type
label
The LHRH antagonist cetrorelix: a review.
@ast
The LHRH antagonist cetrorelix: a review.
@en
The LHRH antagonist cetrorelix: a review.
@nl
prefLabel
The LHRH antagonist cetrorelix: a review.
@ast
The LHRH antagonist cetrorelix: a review.
@en
The LHRH antagonist cetrorelix: a review.
@nl
P2093
P356
P1476
The LHRH antagonist cetrorelix: a review.
@en
P2093
A V Schally
H Riethmiiller
P Bouchard
T Reissmann
P304
P356
10.1093/HUMUPD/6.4.322
P577
2000-07-01T00:00:00Z